Education
About Us
Working with TipRanks
Follow Us
Appili Therapeutics Inc Class A (APLIF)
OTHER OTC:APLIF
Total Valuation
Appili Therapeutics Inc Class A has a market cap or net worth of $2.22M. The enterprise value is $13.05M.
Market Cap$2.22M
Enterprise Value$13.05M
Share Statistics
Appili Therapeutics Inc Class A has 121,266,120 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding121,266,120
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Appili Therapeutics Inc Class A’s return on equity (ROE) is 0.35 and return on invested capital (ROIC) is 80.42%.
Return on Equity (ROE)0.35
Return on Assets (ROA)-2.54
Return on Invested Capital (ROIC)80.42%
Return on Capital Employed (ROCE)0.22
Revenue Per Employee103.43K
Profits Per Employee-472.61K
Employee Count8
Asset Turnover0.56
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Appili Therapeutics Inc Class A is ―. Appili Therapeutics Inc Class A’s PEG ratio is 0.02.
PE Ratio―
PS Ratio5.13
PB Ratio-0.39
Price to Fair Value-0.39
Price to FCF-1.70
Price to Operating Cash Flow3.05
PEG Ratio0.02
Income Statement
In the last 12 months, Appili Therapeutics Inc Class A had revenue of 827.41K and earned -3.78M in profits. Earnings per share was -0.03.
Revenue827.41K
Gross Profit827.41K
Operating Income-2.16M
Pretax Income-3.71M
Net Income-3.78M
EBITDA-2.07M
Earnings Per Share (EPS)-0.03
Cash Flow
In the last 12 months, operating cash flow was -173.87K and capital expenditures -702.00, giving a free cash flow of -174.57K billion.
Operating Cash Flow-173.87K
Free Cash Flow-174.57K
Free Cash Flow per Share>-0.01
Dividends & Yields
Appili Therapeutics Inc Class A pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.09
52-Week Price Change0.00%
50-Day Moving Average0.02
200-Day Moving Average0.02
Relative Strength Index (RSI)52.86
Average Volume (3m)43.77K
Important Dates
Appili Therapeutics Inc Class A upcoming earnings date is Feb 17, 2026, After Close (Confirmed).
Last Earnings DateNov 13, 2025
Next Earnings DateFeb 17, 2026
Ex-Dividend Date―
Financial Position
Appili Therapeutics Inc Class A as a current ratio of 0.13, with Debt / Equity ratio of -84.43%
Current Ratio0.13
Quick Ratio0.13
Debt to Market Cap1.93
Net Debt to EBITDA-3.86
Interest Coverage Ratio-1.33
Taxes
In the past 12 months, Appili Therapeutics Inc Class A has paid 69.58K in taxes.
Income Tax69.58K
Effective Tax Rate-0.02
Enterprise Valuation
Appili Therapeutics Inc Class A EV to EBITDA ratio is -5.88, with an EV/FCF ratio of -4.95.
EV to Sales14.91
EV to EBITDA-5.88
EV to Free Cash Flow-4.95
EV to Operating Cash Flow-5.01
Balance Sheet
Appili Therapeutics Inc Class A has $348.68K in cash and marketable securities with $12.22M in debt, giving a net cash position of -$11.87M billion.
Cash & Marketable Securities$348.68K
Total Debt$12.22M
Net Cash-$11.87M
Net Cash Per Share-$0.10
Tangible Book Value Per Share-$0.09
Margins
Gross margin is 92.34%, with operating margin of -261.39%, and net profit margin of -456.96%.
Gross Margin92.34%
Operating Margin-261.39%
Pretax Margin-448.55%
Net Profit Margin-456.96%
EBITDA Margin-253.37%
EBIT Margin-251.43%
Analyst Forecast
The average price target for Appili Therapeutics Inc Class A is ―, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target―
Price Target Upside―
Analyst ConsensusHold
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―